(Q30482552)

22 June 2017

1 reference

title

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). (English)

1 reference

22 June 2017

Heinz Grunze

10

0 references

Lori L. Altshuler

series ordinal

3

object named as

Lori L Altshuler

1 reference

22 June 2017

2

Gabriele S Leverich

1 reference

22 June 2017

7

Susan L McElroy

1 reference

22 June 2017

4

Mark A Frye

1 reference

22 June 2017

5

Trisha M Suppes

1 reference

22 June 2017

1

Robert M Post

1 reference

22 June 2017

6

Paul E Keck

1 reference

22 June 2017

8

Ralph Kupka

1 reference

22 June 2017

9

Willem A Nolen

1 reference

22 June 2017

11

Jorg Walden

1 reference

22 June 2017

publication date

1 October 2003

1 reference

22 June 2017

1 reference

22 June 2017

volume

5

1 reference

22 June 2017

issue

5

1 reference

22 June 2017

page(s)

310-319

1 reference

The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.

22 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Lamotrigine for the treatment of bipolar disorder: a clinical case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Tiagabine in treatment refractory bipolar disorder: a clinical case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Olanzapine in treatment-resistant bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Lithium and recurrence in a long-term follow-up of bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Early physical and sexual abuse associated with an adverse course of bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Does lithium treatment still work? Evidence of stable responses over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

The Stanley Foundation Bipolar Network. I. Rationale and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

The inventory for depressive symptomatology (IDS): Preliminary findings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

The Stanley Foundation Bipolar Treatment Outcome Network

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Gabapentin in the acute treatment of refractory bipolar disorder.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Outcome of bipolar disorder on long-term treatment with lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Recurrence in affective disorder. I. Case register study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Effects of early adverse experiences on brain structure and function: clinical implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Tardive dyskinesia in bipolar affective disorder: a catchment area study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Predictors of lithium prophylaxis effectiveness

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Who responds to prophylactic lithium?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00051.X

7 January 2021

10.1034/J.1399-5618.2003.00051.X

Identifiers

DOI

1 reference

22 June 2017

1 reference